Masitinib
High-Quality API for Veterinary Drug Manufacturing
Masitinib is a selective tyrosine kinase inhibitor widely used in veterinary oncology, especially for managing canine mast cell tumors. At Origin BioPharma, we supply pharmaceutical-grade Masitinib API with verified purity, validated analytical methods, and complete regulatory documentation to support product development and commercial manufacturing.
Product Description
- ▸ CAS Number: 790299-79-5
- ▸ Molecular Formula: C₂₈H₃₀N₆OS
- ▸ Molar Mass: 498.64 g/mol
- ▸ Appearance: Powder
- ▸ Melting Point: 90–95°C
- ▸ Refractive Index: 1.682
- ▸ Color: Off-white to pale beige
- ▸ Storage: Refrigerated
Solubility Profile
DMSO: ~200 mM | Ethanol: ~4 mg/mL | Water: < 1 mg/mL
Analytical Validation
Each batch is released with rigorous quality control documentation:
▸ Certificate of Analysis (COA) with identity and assay results
▸ HPLC and NMR-validated testing protocols
▸ Comprehensive impurity and residual solvent reports
Veterinary Applications
Ideal for formulating oral tablets or capsules targeting canine mast cell tumors via c-Kit and PDGFR inhibition.
Supports research in anti-inflammatory therapies and targeted veterinary medicine with high excipient compatibility.
Supply & Quality Assurance
▸ Flexible Supply: Grams for R&D up to multi-kilogram commercial batches.
▸ Packaging: Moisture-resistant, sealed containers with cold-chain options available.
▸ Technical Support: Stability reports and full regulatory data sheets provided.
Partner With Origin BioPharma
We assist manufacturers at every stage, from formulation testing to routine production. To request a quotation or a sample, please share your intended dosage form and estimated annual consumption.
Hot Tags: masitinib for veterinary cas 790299-79-5, China masitinib for veterinary cas 790299-79-5 manufacturers, suppliers, factory, 69770-45-2, Toceranib, 138261-41-3, Imidacloprid, 356068-94-5, 13647-35-3
